drugset / Trial / NCT04364607

IM Neostigmine for Accelerating Bladder Emptying After CS by Spinal Anesthesia

NCT04364607

Phase 4 Completed 100 enrolled Mansoura University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The aim of this study is to assess the efficacy of IM neostigmine (0.5 mg) for acceleration of bladder evacuation and prevention of postoperative urine retention following cesarean delivery carried out under spinal anesthesia

Timeline

Start
2020-08-05
Primary completion
2021-10-26
Completion
2021-10-26

Drugs

EvaluationDrugModalityDoseRoute
Comparator Neostigmine Other / unclassified 0.5 mg Intramuscular

Indications

No indication recorded.